Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ADD. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104098518B offers azide-free triazole synthesis. Enhances supply chain safety and reduces manufacturing costs for pharmaceutical intermediates globally.
Novel Mo/Cu co-catalyzed method for high-purity triazole intermediates. Reduces steps and improves yield for pharmaceutical manufacturing.
Patent CN113307778A details a novel Mo-Cu co-catalyzed synthesis of 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate supply.
Patent CN107935820A enables efficient synthesis of brominated bisphenol A derivatives. This report details supply chain advantages and high-purity manufacturing capabilities.
Patent CN108794412B details a high-yield base-promoted cyclization for 4,5-diaryl-1,2,3-triazoles, offering significant cost reduction in API manufacturing and superior purity profiles.
Novel patent CN118126005B details metal-free synthesis for high-purity intermediates. Enables cost reduction and scalable supply chain reliability for global pharmaceutical manufacturing partners.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for critical API building blocks, ensuring supply chain stability.
Efficient Ag2CO3 catalyzed synthesis of polysubstituted pyrroles from alkynes and isocyanides. Cost-effective pharma intermediate manufacturing with high purity.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for critical API building blocks, ensuring supply chain stability.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113307778A reveals a mild Mo/Cu-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113735778B reveals efficient silver oxide promoted synthesis. Enables cost reduction in pharmaceutical manufacturing with high purity.
Patent CN118126005B reveals a metal-free route for fluorinated heterocycles. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel iridium-catalyzed synthesis offers high purity and cost efficiency for pharmaceutical intermediates. Enhances supply chain reliability for anti-colon cancer drug development.
Patent CN109096138B reveals a robust Pd-catalyzed route for alpha-amino ketones using 2H-aziridines, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction in API manufacturing and scalable production.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction and scalability for pharma manufacturing.
Novel Ag2O-catalyzed cyclization for 5-CF3 imidazoles. High yield, scalable process for pharma intermediates. Cost-effective supply chain solution.
Patent CN112194548A reveals a mild copper-catalyzed decarboxylative [3+2] cycloaddition for constructing complex lactones, offering significant cost reduction in API manufacturing.
Patent CN110437128B details a mild Ni(II) method for 3-thioether isoindolinones, offering high yields and cost-effective manufacturing for pharmaceutical supply chains.